Position in GHRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,310,389
+$1,389,966 QoQ
Shares Held
85,952
+31.3% QoQ
Ownership
0.125%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 62 holders
Holding Since
Jun 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GHRS Over Time
Shares Held
Position Value (USD)
Derivatives in GHRS
reported options exposure · as of Jun 30, 2026CallValue
$532,224
CallShares
19,800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. GHRS ranks #196 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
1,425,517 | $406,229,578 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
3,760,028 | $280,046,885 | |
| 3 | INSM |
INSMED Inc
|
2,556,973 | $272,624,460 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
507,233 | $272,358,759 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
510,430 | $253,545,893 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,006,676 | $242,578,715 | |
| 7 | MANE |
Veradermics, Inc
|
1,877,775 | $230,853,658 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,576,261 | $197,343,876 |
All Filings in GHRS
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $532,224 | 19,800 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $2,310,389 | 85,952 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $920,423 | 65,464 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $333,476 | 26,258 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $156,210 | 12,300 | Call | Defined | 2026-02-17 | |
| 2025-09-30 | $1,349,948 | 94,402 | Shares | Defined | 2025-11-14 | |
| 2025-03-31 | $30,884 | 2,800 | Put | Defined | 2025-05-15 | |
| 2025-03-31 | $171,913 | 15,586 | Shares | Defined | 2025-05-15 | |
| 2025-03-31 | $55,150 | 5,000 | Call | Defined | 2025-05-15 | |
| 2024-09-30 | $1,443,146 | 215,717 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $8,028 | 1,200 | Put | Defined | 2024-11-14 | |
| 2024-09-30 | $18,732 | 2,800 | Call | Defined | 2024-11-14 | |
| 2024-06-30 | $37,312 | 3,200 | Call | Defined | 2024-08-14 | |
| 2024-06-30 | $1,836,356 | 157,492 | Shares | Defined | 2024-08-14 | |
| 2024-06-30 | $3,498 | 300 | Put | Defined | 2024-08-14 | |
| 2024-03-31 | $22,386 | 2,100 | Put | Defined | 2024-05-15 | |
| 2024-03-31 | $2,132 | 200 | Call | Defined | 2024-05-15 | |
| 2024-03-31 | $130,137 | 12,208 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $563,956 | 97,234 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,687,605 | 167,921 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,715,334 | 144,571 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,155,018 | 144,558 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $12,452,475 | 1,281,119 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $14,967,744 | 1,288,102 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $13,008,630 | 1,303,470 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $23,333,138 | 1,275,732 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $29,762,827 | 1,275,732 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $28,956,969 | 1,312,646 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $27,896,756 | 1,283,790 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||